Report - Program PDF Saturday, March 9, 2013 Updated: 01-24-13...Rivaroxaban in the Setting of Continued Dual Antiplatelet Therapy: Findings from the ATLAS ACS 2‐TIMI 51 Trial Jessica L.

Please pass captcha verification before submit form